Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,291 | 17,529 | 23,479 | 16,821 | 15,310 |
| Marketable Securities | 47,766 | 66,773 | 76,270 | 57,328 | 67,998 |
| Other current assets | 0 | 0 | 86 | 723 | 830 |
| TOTAL | $71,613 | $87,048 | $113,430 | $88,772 | $100,570 |
| Non-Current Assets | |||||
| PPE Net | 62,157 | 65,089 | 67,921 | 76,885 | 77,273 |
| Investments And Advances | 10,746 | 10,736 | 13,441 | 14,201 | 21,085 |
| Intangibles | 0 | 0 | 0 | 565 | 1,130 |
| Other Non-Current Assets | 15,691 | 12,823 | 13,469 | 1,527 | 1,583 |
| TOTAL | $88,594 | $88,648 | $94,831 | $93,178 | $101,071 |
| Total Assets | $160,207 | $175,696 | $208,261 | $181,950 | $201,641 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,983 | 2,884 | 4,335 | 4,489 | 5,700 |
| Accrued Expenses | 5,251 | 6,466 | 20,242 | 21,104 | 22,785 |
| Other current liabilities | 4,285 | 3,080 | 3,124 | 1,667 | 1,919 |
| TOTAL | $12,519 | $12,430 | $27,701 | $27,260 | $30,404 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,732 | 11,997 | 12,752 | 0 | 24 |
| TOTAL | $11,732 | $11,997 | $12,752 | $8,684 | $9,151 |
| Total Liabilities | $24,251 | $24,427 | $40,453 | $35,944 | $39,555 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,367 | 98,308 | 98,674 | 79,088 | 79,226 |
| Common Shares | 10 | 10 | 10 | 8 | 8 |
| Retained earnings | -646,550 | -630,969 | -613,786 | -594,981 | -577,413 |
| Other shareholders' equity | -53 | -84 | -206 | -267 | -348 |
| TOTAL | $135,956 | $151,269 | $167,808 | $146,006 | $162,086 |
| Total Liabilities And Equity | $160,207 | $175,696 | $208,261 | $181,950 | $201,641 |